Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cytokinetics Inc. buy Evercore ISI

Start price
€40.60
11.02.25 / 50%
Target price
-
11.02.26
Performance (%)
40.39%
End price
€57.00
12.02.26
Summary
This prediction ended on 12.02.26 with a price of €57.00. With a performance of 40.39% the BUY prediction by Evercore_ISI was a big success. Evercore_ISI has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Evercore_ISI has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Cytokinetics Inc. 3.571% 3.571% 19.342%
iShares Core DAX® 1,43 % 2,63 % 12,46 %
iShares Nasdaq 100 1,89 % -0,46 % 1,25 %
iShares Nikkei 225® -1,62 % 11,10 % 27,38 %
iShares S&P 500 1,92 % 1,16 % 1,63 %

Comments by Evercore_ISI for this prediction

In the thread Discuss Cytokinetics Inc.

Cytokinetics, Incorporated (NASDAQ: CYTK) was upgraded by analysts at Evercore ISI to a "strong-buy" rating.
Ratings data for CYTK provided by MarketBeat

In the thread Trading Cytokinetics Inc.
Prediction Buy
Perf. (%) 40.39%
Target price
Change
Ends at 11.02.26

Die von Evercore_ISI gewählte maximale Laufzeit wurde überschritten

Current prediction by Evercore_ISI for Cytokinetics Inc.

buy
Cytokinetics Inc.

Start price
Target price
Perf. (%)
€41.60
03.09.25
€68.78
03.09.26
39.42%
20.02.26